• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION PROMUS ELITE; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION PROMUS ELITE; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number 10676
Device Problems Failure to Advance (2524); Material Deformation (2976)
Patient Problems No Consequences Or Impact To Patient (2199); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/07/2021
Event Type  malfunction  
Event Description
It was reported that stent damage occurred.Vascular access was obtained via right femoral artery.The 90% stenosed, concentric, de novo target lesion containing >45 and <90 degrees bend was located in the moderate to severely tortuous and moderately calcified right coronary artery.After engaging the lesion with a 6f jr 3.5 guide catheter and a non-bsc wire, pre-dilatation was performed with a non-bsc balloon.A 32 x 3.50 promus elite mr drug eluting stent was advanced to treat the lesion.However, the device failed to cross lesion and the stent strut was damaged.The device was removed and the procedure was completed with another of the same device.There were no complications reported and the patient was stable.
 
Event Description
It was reported that stent damage occurred.Vascular access was obtained via right femoral artery.The 90% stenosed, concentric, de novo target lesion containing >45 and <90 degrees bend was located in the moderate to severely tortuous and moderately calcified right coronary artery.After engaging the lesion with a 6f jr 3.5 guide catheter and a non-bsc wire, pre-dilatation was performed with a non-bsc balloon.A 32 x 3.50 promus elite mr drug eluting stent was advanced to treat the lesion.However, the device failed to cross lesion and the stent strut was damaged.The device was removed and the procedure was completed with another of the same device.There were no complications reported and the patient was stable.
 
Manufacturer Narrative
Device evaluated by mfr: promus elite ous mr 32 x 3.50mm stent delivery system catheter was returned for analysis.A visual examination of the stent found stent damage with struts in the distal region lifted from crimped position and pulled distally.The undamaged stent outer diameter was measured and the result was within maximum crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual examination of the bumper tip showed no signs of damage.A visual and tactile examination of the hypotube found multiple hypotube kinks.A visual examination of the outer and inner lumen and mid-shaft section found no issues along the shaft polymer extrusion.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELITE
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
MDR Report Key11174205
MDR Text Key227018772
Report Number2134265-2021-00337
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 02/25/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/15/2021
Device Model Number10676
Device Catalogue Number10676
Device Lot Number0023865218
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/28/2021
Initial Date Manufacturer Received 01/07/2021
Initial Date FDA Received01/14/2021
Supplement Dates Manufacturer Received02/18/2021
Supplement Dates FDA Received02/25/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age47 YR
-
-